1. Strategies to overcome acquired resistance to EGFR TKI in the treatment of non-small cell lung cancer
   J. Gao et al, 2019, Clinical and Translational Oncology CrossRef
2. 6-Shogaol Overcomes Gefitinib Resistance via ER Stress in Ovarian Cancer Cells
   Tae Woo Kim et al, 2023, International Journal of Molecular Sciences CrossRef
3. Zoledronic acid increases the antitumor effect of gefitinib treatment for non-small cell lung cancer with EGFR mutations
   CHENGJUN FENG et al, 2016, Oncology Reports CrossRef
4. Sequentially administrated of pemetrexed with icotinib/erlotinib in lung adenocarcinoma cell lines in vitro
   Xiuli Feng et al, 2017, Oncotarget CrossRef
5. Phosphorylation and Acetylation of Proteins as Posttranslational Modification: Implications in Human Health and Associated Diseases
   Sana Qausain et al, 2019, Protein Modificomics CrossRef
6. Synergistic Antitumor Activity of SH003 and Docetaxel via EGFR Signaling Inhibition in Non-Small Cell Lung Cancer
   Mi-So Jeong et al, 2021, International Journal of Molecular Sciences CrossRef
7. The cell line models to study tyrosine kinase inhibitors in non-small cell lung cancer with mutations in the epidermal growth factor receptor: A scoping review
   Alessia Belloni et al, 2024, Critical Reviews in Oncology/Hematology CrossRef
8. First-line therapy for advanced non-small cell lung cancer with activating EGFR mutation: is combined EGFR-TKIs and chemotherapy a better choice?
   Shuyun Wang et al, 2018, Cancer Chemotherapy and Pharmacology CrossRef
9. An Activatable Nano‐Prodrug for Treating Tyrosine‐Kinase‐Inhibitor‐Resistant Non‐Small Cell Lung Cancer and for Optoacoustic and Fluorescent Imaging
   Xin Xie et al, 2020, Small CrossRef
10. Chemotherapy and intercalated gefitinib or erlotinib in the treatment of advanced non-small-cell lung cancer
    Antonio Rossi et al, 2017, Expert Review of Respiratory Medicine CrossRef
11. Anticancer Activity of Mannose-Specific Lectin, BPL2, from Marine Green Alga Bryopsis plumosa
    Jei Ha Lee et al, 2022, Marine Drugs CrossRef
12. Intercalated Chemotherapy and Epidermal Growth Factor Receptor Inhibitors for Patients With Advanced Non–Small-cell Lung Cancer: A Systematic Review and Meta-analysis
    Anna La Salvia et al, 2017, Clinical Lung Cancer CrossRef
13. Role of hypoxia-inducible factor-1α and CD146 in epidermal growth factor receptor-mediated angiogenesis in salivary gland adenoid cystic carcinoma
    WEI-MING WANG et al, 2015, Molecular Medicine Reports CrossRef